Fred H. Geisler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fred H. Geisler has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Ali Moghaddamjou
Division of Neurosurgery, Department of Surgery, University of Toronto and Spinal Program, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; and
1 shared publicationJamie R. F. Wilson
Department of Neurosurgery, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska
1 shared publicationMichael G. Fehlings
Division of Neurosurgery, Department of Surgery, University of Toronto and Spinal Program, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; and
1 shared publication
Latest Publications
- Open Access
- 1 May 2023
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 38 (5) , 595-606
Methylprednisolone in acute traumatic spinal cord injury: case-matched outcomes from the NASCIS2 and Sygen historical spinal cord injury studies with contemporary statistical analysis
OBJECTIVE: Methylprednisolone (MP) to treat acute traumatic spinal cord injury (ATSCI) remains controversial since the release of the second National Acute Spinal Cord Injury Study (NASCIS2) in 1990. As two historical studies, NASCIS2 and Sygen in ATSCI, used identical MP dosages, it was possible to construct a new case-level pooled ATSCI data set satisfying contemporary criteria and able to clarify the effect of MP. METHODS: The new pooled data set was first modernized by excluding patients with injury levels caudal to T10, lower-extremity American Spinal Injury Association (ASIA) motor scores (LEMSs) ≥ 46, Glasgow Coma Scale scores ≤ 11, and age < 15 or > 75 years, and then standardized to the ASIA grading and scoring format. A new updated NASCIS2 data set from this pooled data set contained 31.6% fewer patients than the 1990 NASCIS2 data set. RESULTS: In the new pooled data set, recovery of LEMSs from baseline to 26 weeks, the primary outcome variable, was separated statistically into five different injury severity cohorts (p < 0.0001). The severity cohorts contained groups with severe floor (62.9%) and ceiling (10.7%) effects, which do not contribute to drug effects. The new NASCIS2 data set duplicated the p value for MP versus placebo in the sub-subgroup analysis of MP initiated ≤ 8 hours (the subgroup) and recovery of motor function on only the right side of the body (a further subgroup within the ≤ 8-hour subgroup), presented as the positive MP effect in the original NASCIS2 reporting. However, current statistical interpretation considers results seen only in post hoc sub-subgroups, without multi-test corrections, to be random effects without clinical significance. The combined case-level pooled data set from the NASCIS2 and Sygen studies increased the MP group from 106 to 431 patients, creating a new MP combined group. This new data set served as a surrogate for a contemporary MP study and found that administration of MP did not enhance ASIA motor score improvement in the lower extremities at 26 weeks. Secondary analysis of descending ASIA motor and sensory cervical neurological levels in cervical ATSCI patients at 26 weeks also found no MP drug effect. CONCLUSIONS: Analysis of both the new updated NASCIS2 data set and the new case-matched pooled data set from two historical ATSCI studies revealed that administration of MP after spinal cord injury did not demonstrate any enhancement in neurological recovery at 26 weeks. The results of this analysis warrant review by clinical guideline groups.
- 1 May 2023
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 38 (5) , 595-606
Open AccessMethylprednisolone in acute traumatic spinal cord injury: case-matched outcomes from the NASCIS2 and Sygen historical spinal cord injury studies with contemporary statistical analysis
OBJECTIVE: Methylprednisolone (MP) to treat acute traumatic spinal cord injury (ATSCI) remains controversial since the release of the second National Acute Spinal Cord Injury Study (NASCIS2) in 1990. As two historical studies, NASCIS2 and Sygen in ATSCI, used identical MP dosages, it was possible to construct a new case-level pooled ATSCI data set satisfying contemporary criteria and able to clarify the effect of MP. METHODS: The new pooled data set was first modernized by excluding patients with injury levels caudal to T10, lower-extremity American Spinal Injury Association (ASIA) motor scores (LEMSs) ≥ 46, Glasgow Coma Scale scores ≤ 11, and age < 15 or > 75 years, and then standardized to the ASIA grading and scoring format. A new updated NASCIS2 data set from this pooled data set contained 31.6% fewer patients than the 1990 NASCIS2 data set. RESULTS: In the new pooled data set, recovery of LEMSs from baseline to 26 weeks, the primary outcome variable, was separated statistically into five different injury severity cohorts (p < 0.0001). The severity cohorts contained groups with severe floor (62.9%) and ceiling (10.7%) effects, which do not contribute to drug effects. The new NASCIS2 data set duplicated the p value for MP versus placebo in the sub-subgroup analysis of MP initiated ≤ 8 hours (the subgroup) and recovery of motor function on only the right side of the body (a further subgroup within the ≤ 8-hour subgroup), presented as the positive MP effect in the original NASCIS2 reporting. However, current statistical interpretation considers results seen only in post hoc sub-subgroups, without multi-test corrections, to be random effects without clinical significance. The combined case-level pooled data set from the NASCIS2 and Sygen studies increased the MP group from 106 to 431 patients, creating a new MP combined group. This new data set served as a surrogate for a contemporary MP study and found that administration of MP did not enhance ASIA motor score improvement in the lower extremities at 26 weeks. Secondary analysis of descending ASIA motor and sensory cervical neurological levels in cervical ATSCI patients at 26 weeks also found no MP drug effect. CONCLUSIONS: Analysis of both the new updated NASCIS2 data set and the new case-matched pooled data set from two historical ATSCI studies revealed that administration of MP after spinal cord injury did not demonstrate any enhancement in neurological recovery at 26 weeks. The results of this analysis warrant review by clinical guideline groups.
- 1 July 2013
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 35 (v2suppleme) , Video8
Stabilization of the sacroiliac joint with the SI-Bone surgical technique
Although the motion of the sacroiliac joints (SIJ) is minimal, pain can originate from the SIJ on mechanical loading and affect walking, sitting and sleep patterns. The SIJ refers to the pair of joints inferior to the L5-S1 joint, and functions as the inferior adjacent level after a L5-S1 fusion. SIJ pain has a clinical overlay of symptoms often similar to low back pain (LBP) generated by the lumbar spine. The differential diagnosis in any patient with LBP should include the triad of low back, SIJ, and hip. SIJ pain is also a known cause of residual LBP after successful lumbar fusion. Relief of the patient's pain with a diagnostic SIJ block verifies the SIJ as the site of the pain generator. The SI-bone technique of stabilization of the SIJ is a true minimally invasive surgical technique performed through an initial small skin incision and then over pins, with the aid of fluoroscopy in three orthogonal axes with one axis parallel to the posterior sacral cortical line at the S1 to S2 region. The fluoroscopy procedure includes the following steps: 1) pre-op plan of the desired 3 implant trajectories to account for the anatomic variations; 2) placement of 3 Steinman pins at these trajectories across the SIJ starting in a small skin incision; 3) drill, broach and then implant placement as a cannulated system. All these steps are performed with the assistance of fluoroscopy in all three imaging planes – lateral, inlet and outlet views. The SI-Bone implants are triangular shaped titanium and have a rough surface for immediate stability. This rough surface is believed to aid in the osteo-fixation of the implants to the ilium and sacrum, as well as to long term fusion of the SIJ after its prolonged immobilization. The video can be found here: http://youtu.be/2YtFddohZRk .
- 1 July 2013
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 35 (v2suppleme) , Video8
Stabilization of the sacroiliac joint with the SI-Bone surgical technique
Although the motion of the sacroiliac joints (SIJ) is minimal, pain can originate from the SIJ on mechanical loading and affect walking, sitting and sleep patterns. The SIJ refers to the pair of joints inferior to the L5-S1 joint, and functions as the inferior adjacent level after a L5-S1 fusion. SIJ pain has a clinical overlay of symptoms often similar to low back pain (LBP) generated by the lumbar spine. The differential diagnosis in any patient with LBP should include the triad of low back, SIJ, and hip. SIJ pain is also a known cause of residual LBP after successful lumbar fusion. Relief of the patient's pain with a diagnostic SIJ block verifies the SIJ as the site of the pain generator. The SI-bone technique of stabilization of the SIJ is a true minimally invasive surgical technique performed through an initial small skin incision and then over pins, with the aid of fluoroscopy in three orthogonal axes with one axis parallel to the posterior sacral cortical line at the S1 to S2 region. The fluoroscopy procedure includes the following steps: 1) pre-op plan of the desired 3 implant trajectories to account for the anatomic variations; 2) placement of 3 Steinman pins at these trajectories across the SIJ starting in a small skin incision; 3) drill, broach and then implant placement as a cannulated system. All these steps are performed with the assistance of fluoroscopy in all three imaging planes – lateral, inlet and outlet views. The SI-Bone implants are triangular shaped titanium and have a rough surface for immediate stability. This rough surface is believed to aid in the osteo-fixation of the implants to the ilium and sacrum, as well as to long term fusion of the SIJ after its prolonged immobilization. The video can be found here: http://youtu.be/2YtFddohZRk .